Premium
Ultrasound‐Guided Prolotherapy for Acromial Enthesopathy and Acromioclavicular Joint Arthropathy: A Single‐Arm Prospective Study
Author(s) -
Hsieh PeiChun,
Chiou HongJen,
Wang HsinKai,
Lai YiChen,
Lin YungHui
Publication year - 2019
Publication title -
journal of ultrasound in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.574
H-Index - 91
eISSN - 1550-9613
pISSN - 0278-4297
DOI - 10.1002/jum.14727
Subject(s) - medicine , prolotherapy , enthesopathy , visual analogue scale , acromioclavicular joint , arthropathy , surgery , shoulders , osteoarthritis , physical therapy , arthritis , alternative medicine , pathology
Objectives Prolotherapy is an injection‐based complementary treatment for various musculoskeletal diseases. The aim of this study was to evaluate the therapeutic efficacy of ultrasound‐guided prolotherapy in the treatment of acromial enthesopathy and acromioclavicular joint arthropathy. Methods Thirty‐one patients with chronic moderate‐to‐severe shoulder pain were recruited from September 2015 to September 2017. Ultrasound‐guided prolotherapy was performed by injecting 10 mL of a 15% dextrose solution into the acromial enthesis of the deltoid or acromioclavicular joint capsule aseptically. Prolotherapy was given in 2 sessions separated by a 1‐month interval. The pretreatment‐to‐posttreatment change in the pain visual analog scale (VAS) score was recorded as the primary outcome. The mean follow‐up duration was 61.8 days. A paired t test was used to assess the difference in pretreatment and posttreatment VAS scores. A univariate logistic regression analysis was conducted to identify the demographic variables associated with substantial pain reduction after the intervention. Substantial pain reduction was defined as a posttreatment VAS score of 3 or less. Results Twenty of the 31 patients reported substantial pain reduction without adverse effects after the intervention. The mean VAS score reduction ± SD was 4.3 ± 2.6 (pretreatment, 6.8 ± 1.5; posttreatment, 2.5 ± 2.1; P < .01). Conclusions Ultrasound‐guided prolotherapy with a 15% dextrose solution is an effective and safe therapeutic option for moderate‐to‐severe acromial enthesopathy and acromioclavicular joint arthropathy.